NDC 58468-0348 – Qfitlia

Fitusiran 50 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC58468-0348

Product details

Brand name
Qfitlia
Generic name
fitusiran
Labeler
Genzyme Corporation
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA219019
Marketed since
March 28, 2025
Listing expires
December 31, 2026
Pharmacologic class
Antithrombin-directed RNA Interaction; Small Interfering RNA

Active ingredients

Uses, dosage, side effects and warnings for Qfitlia →

Package NDC codes (1)

Package NDCDescriptionSince
58468-0348-11 SYRINGE in 1 CARTON (58468-0348-1) / .5 mL in 1 SYRINGEMar 28, 2025

Other Qfitlia products